Marchionni; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marchionni; Mark.The latest application filed is for "methods for cardiomyocyte survival, proliferation or differentiation by nrg-2".

Company Profile

3.21.15

Marchionni; Mark - Arlington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Cardiomyocyte Survival, Proliferation Or Differentiation By Nrg-2 App 20200354422 - Marchionni; Mark	2020-11-12
Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2 Grant 10,717,775 - Marchionni	2020-07-21
Methods For Protecting Dopaminergic Neurons From Stress And Promoting Proliferation And Differentiation Of Oligodendrocyte Proge App 20190169248 - Marchionni; Mark	2019-06-06
Methods for treating congestive heart failure Grant 10,232,016 - Marchionni , et al.	2019-03-19
Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 Grant 10,065,999 - Marchionni September 4, 2	2018-09-04
Methods for Treating Congestive Heart Failure App 20160113998 - Marchionni; Mark ; et al.	2016-04-28
Methods For Protecting Dopaminergic Neurons From Stress And Promoting Proliferation And Differentiation Of Oligodendrocyte Progenitors By Nrg-2 App 20150274795 - Marchionni; Mark	2015-10-01
Methods for treating congestive heart failure Grant 8,394,761 - Marchionni , et al. March 12, 2	2013-03-12
Methods For Treating Congestive Heart Failure App 20130040879 - Marchionni; Mark ; et al.	2013-02-14
Methods For Protecting Dopaminergic Neurons From Stress And Promoting Proliferation And Differentiation Of Oligodendrocyte Progenitors By Nrg-2 App 20120214737 - Marchionni; Mark	2012-08-23
Methods For Treating Congestive Heart Failure App 20120065130 - Marchionni; Mark ; et al.	2012-03-15
Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 Grant 8,114,838 - Marchionni February 14, 2	2012-02-14
Methods for treating congestive heart failure Grant 8,076,283 - Marchionni , et al. December 13, 2	2011-12-13
Methods for treating muscle diseases and disorders Grant 8,026,213 - Sklar , et al. September 27, 2	2011-09-27
Glial mitogenic factors, their preparation and use Grant 7,968,678 - Goodearl , et al. June 28, 2	2011-06-28
Methods For Treating Muscle Diseases And Disorders App 20110144015 - Sklar; Robert ; et al.	2011-06-16
Methods for treating congestive heart failure App 20100267618 - Marchionni; Mark ; et al.	2010-10-21
Methods for treating muscle diseases and disorders Grant 7,718,606 - Sklar , et al. May 18, 2	2010-05-18
Methods for treating congestive heart failure Grant 7,662,772 - Marchionni , et al. February 16, 2	2010-02-16
Glial mitogenic factors, their preparation and use App 20090246867 - Goodearl; Andrew David ; et al.	2009-10-01
Methods for treating muscle diseases and disorders App 20090018073 - Sklar; Robert ; et al.	2009-01-15
Methods for treating muscle diseases and disorders Grant 7,384,756 - Sklar , et al. June 10, 2	2008-06-10
Glial mitogenic factors lacking an N-terminal signal sequence Grant 7,319,019 - Goodearl , et al. January 15, 2	2008-01-15
Methods for treating congestive heart failure App 20070196379 - Marchionni; Mark ; et al.	2007-08-23
Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III Grant 7,115,554 - Sklar , et al. October 3, 2	2006-10-03
Methods for treating muscle diseases and disorders Grant 7,037,888 - Sklar , et al. May 2, 2	2006-05-02
NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods App 20050261186 - Marchionni, Mark	2005-11-24
NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods Grant 6,890,751 - Marchionni May 10, 2	2005-05-10
Methods for treating neurological injuries and disorders Grant 6,872,698 - Marchionni , et al. March 29, 2	2005-03-29
Methods for treating congestive heart failure Grant 6,635,249 - Marchionni , et al. October 21, 2	2003-10-21
Methods for treating neurological injuries and disorders App 20030069176 - Marchionni, Mark ; et al.	2003-04-10
Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin Grant 6,444,642 - Sklar , et al. September 3, 2	2002-09-03
NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods App 20020081286 - Marchionni, Mark	2002-06-27
Method for making antibodies which specifically bind to glial growth factors Grant 5,876,973 - Marchionni March 2, 1	1999-03-02
Glial growth factors Grant 5,716,930 - Goodearl , et al. February 10, 1	1998-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.